Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.2400 (-2.21%) ($39.5500 - $41.4100) on Fri. Nov. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 64 | Latest Price | $40.2400(-2.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.9% a day on average for past five trading days. | Weekly Trend | HALO advances 3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.52% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) EDOC(-8%) TLT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $40.3(-0.15%) | 10 Day Moving Average | $39.78(1.16%) | 20 Day Moving Average | $37.27(7.97%) | To recent high | -2.2% | To recent low | 56.4% | Market Cap | $5.5b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |